Effects of implementing a vaccination tool in the electronic medical record on vaccination coverage of patients with immune-mediated inflammatory diseases: a prospective cohort study.

Inflammatory bowel disease dermatology infectious diseases rheumatology vaccination

Journal

Infectious diseases (London, England)
ISSN: 2374-4243
Titre abrégé: Infect Dis (Lond)
Pays: England
ID NLM: 101650235

Informations de publication

Date de publication:
07 Jun 2024
Historique:
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 7 6 2024
Statut: aheadofprint

Résumé

The rising incidence of immune-mediated inflammatory diseases (IMID) requires innovative management strategies, including effective vaccination. We aimed to assess the impact of an electronic medical record (EMR)-integrated vaccination tool on vaccination coverage among patients with inflammatory bowel diseases (IBD), rheumatological and dermatological conditions. A prospective observational study compared vaccination coverage before (2018) and after (2021) implementing the module. Vaccination data for influenza, pneumococcus, hepatitis B and tetanus, and potential predictors were collected from 1430 IMID patients (44.9% male, median age (interquartile range [IQR]) 54 (40-66) years, 789 with IBD, 604 with rheumatological and 37 with dermatological conditions). Data were analysed using McNemar, chi-square tests and multinominal logistic regression. Significant increases in pneumococcus (56.6% to 73.1%, Increased vaccination coverage was measured after implementing the vaccination tool. The COVID19 pandemic and the 2018 measurement might have increased vaccination awareness. Education of patients and healthcare professionals remains crucial.

Sections du résumé

BACKGROUND UNASSIGNED
The rising incidence of immune-mediated inflammatory diseases (IMID) requires innovative management strategies, including effective vaccination. We aimed to assess the impact of an electronic medical record (EMR)-integrated vaccination tool on vaccination coverage among patients with inflammatory bowel diseases (IBD), rheumatological and dermatological conditions.
METHODS UNASSIGNED
A prospective observational study compared vaccination coverage before (2018) and after (2021) implementing the module. Vaccination data for influenza, pneumococcus, hepatitis B and tetanus, and potential predictors were collected from 1430 IMID patients (44.9% male, median age (interquartile range [IQR]) 54 (40-66) years, 789 with IBD, 604 with rheumatological and 37 with dermatological conditions). Data were analysed using McNemar, chi-square tests and multinominal logistic regression.
RESULTS UNASSIGNED
Significant increases in pneumococcus (56.6% to 73.1%,
CONCLUSIONS UNASSIGNED
Increased vaccination coverage was measured after implementing the vaccination tool. The COVID19 pandemic and the 2018 measurement might have increased vaccination awareness. Education of patients and healthcare professionals remains crucial.

Identifiants

pubmed: 38847612
doi: 10.1080/23744235.2024.2361795
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Auteurs

Liselotte Fierens (L)

Department of Chronic and Metabolic diseases, KU Leuven, Leuven, Belgium.

Sofie Coenen (S)

Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.

Johan Joly (J)

Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium.

Tine Vanhoutvin (T)

Department of Dermatology, University Hospitals Leuven, Leuven, Belgium.

Els De Dycker (E)

Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.

Delphine Bertrand (D)

Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium.
Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Eva Van Laer (E)

Hospital Pharmacy, University Hospitals Leuven, Leuven, Belgium.

Jens Penny (J)

Department of Information Systems - IT, University Hospitals Leuven, Leuven, Belgium.

Jan Reumers (J)

Department of Information Systems - IT, University Hospitals Leuven, Leuven, Belgium.

Patrick Verschueren (P)

Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium.
Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Petra De Haes (P)

Department of Dermatology, University Hospitals Leuven, Leuven, Belgium.
Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Paul De Munter (P)

Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium.

Marc Ferrante (M)

Department of Chronic and Metabolic diseases, KU Leuven, Leuven, Belgium.
Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.

Classifications MeSH